Colonics
About Me
Recent Posts
- 4 Mushroom Poisonings In 2 Weeks - Doctors Test Milk Thistle As Treatment
- Improved Diagnostics For Sleeping Sickness
- Prostate Growth May Be Slowed By Statins
- New Tools For Psychological Science Research - Facebook And Smartphones
- Finding That Oxytocin Improves Brain Function In Children With Autism Could Lead To Treatment For Associated Social Deficits
Menu
Calendar
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 | |||
Friends
Links
Entry 1 of 2380
Last Page | Next Page
9/25/2011
-
Afinitor (Everolimus) Prolongs Advanced Breast Cancer Patients' Progression Free Survival Time
|
Afinitor (evelolimus), a Novartis kidney cancer drug, when combined with hormonal therapy doubled breast cancer patients' progression-free survival, and reduced cancer procession risk by 57% compared to exemestane alone, researchers revealed during a suspensory veto Symposium at the 2011 indo-european language Multidisciplinary Cancer conclave in Stockholm, Sweden. Hervé Hoppenot, President, Novartis Oncology, said: "Everolimus is the first drug to show eloquent efficacy when combined with hormonal therapy in women with ER+HER2- premature breast cancer, where there continues to be a critical unmet need... More: - From the site |
Post A Comment! :: Send to a Friend! |
Share and enjoy
